Am. Nugent et al., STRESS RESPONSES AFTER TREATMENT OF HYPERCHOLESTEROLEMIA WITH SIMVASTATIN, British journal of clinical pharmacology, 36(5), 1993, pp. 474-477
In order to determine whether treatment of hyperlipidaemia with simvas
tatin impairs exercise stress responses and so may contribute to an ex
cess of suicides and violent deaths, the effects of simvastatin 20 mg
daily and placebo on exercise physiology were compared in 19 patients.
After 6 weeks of treatment there was no evidence of reduced exercise
capacity, or of reduced cortisol or catecholamine responses. It is con
cluded that treatment of hyperlipidaemia with an inhibitor of HMG-CoA
reductase does not significantly modify stress responses, and so the e
xplanation for a possible increase in non-cardiac mortality must be so
ught elsewhere.